1023 related articles for article (PubMed ID: 30385170)
1. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.
Ahmad MH; Fatima M; Mondal AC
J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170
[TBL] [Abstract][Full Text] [Related]
2. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
Regen F; Hellmann-Regen J; Costantini E; Reale M
Curr Alzheimer Res; 2017; 14(11):1140-1148. PubMed ID: 28164764
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals.
Sawikr Y; Yarla NS; Peluso I; Kamal MA; Aliev G; Bishayee A
Adv Protein Chem Struct Biol; 2017; 108():33-57. PubMed ID: 28427563
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.
Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A
Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammatory Signaling in the Pathogenesis of Alzheimer's Disease.
Uddin MS; Kabir MT; Jalouli M; Rahman MA; Jeandet P; Behl T; Alexiou A; Albadrani GM; Abdel-Daim MM; Perveen A; Ashraf GM
Curr Neuropharmacol; 2022; 20(1):126-146. PubMed ID: 34525932
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammatory responses in Alzheimer's disease.
Dansokho C; Heneka MT
J Neural Transm (Vienna); 2018 May; 125(5):771-779. PubMed ID: 29273951
[TBL] [Abstract][Full Text] [Related]
8. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
Weisman D; Hakimian E; Ho GJ
Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
[TBL] [Abstract][Full Text] [Related]
9. [Pro-inflammatory cytokines in Alzheimer's disease].
Stamouli EC; Politis AM
Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
[TBL] [Abstract][Full Text] [Related]
10. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease.
Kaur D; Sharma V; Deshmukh R
Inflammopharmacology; 2019 Aug; 27(4):663-677. PubMed ID: 30874945
[TBL] [Abstract][Full Text] [Related]
11. Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review.
Park JC; Han SH; Mook-Jung I
BMB Rep; 2020 Jan; 53(1):10-19. PubMed ID: 31865964
[TBL] [Abstract][Full Text] [Related]
12. A review: inflammatory process in Alzheimer's disease, role of cytokines.
Rubio-Perez JM; Morillas-Ruiz JM
ScientificWorldJournal; 2012; 2012():756357. PubMed ID: 22566778
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
Agostinho P; Cunha RA; Oliveira C
Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease.
Uddin MS; Kabir MT; Mamun AA; Barreto GE; Rashid M; Perveen A; Ashraf GM
Int Immunopharmacol; 2020 Jul; 84():106479. PubMed ID: 32353686
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation in Alzheimer's disease: protector or promoter?
Zilka N; Ferencik M; Hulin I
Bratisl Lek Listy; 2006; 107(9-10):374-83. PubMed ID: 17262990
[TBL] [Abstract][Full Text] [Related]
16. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease.
Al-Ghraiybah NF; Wang J; Alkhalifa AE; Roberts AB; Raj R; Yang E; Kaddoumi A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142483
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease: Innate immunity gone awry?
VanItallie TB
Metabolism; 2017 Apr; 69S():S41-S49. PubMed ID: 28129888
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: Is there a role for galectins?
da Rosa MM; de Aguiar Ferreira M; de Oliveira Lima CA; Santos Mendonça AC; Silva YM; Sharjeel M; de Melo Rego MJB; Pereira MC; da Rocha Pitta MG
Eur J Pharmacol; 2021 Oct; 909():174437. PubMed ID: 34450113
[TBL] [Abstract][Full Text] [Related]
19. The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease.
Salminen A; Kaarniranta K; Kauppinen A
Cell Mol Life Sci; 2018 Sep; 75(17):3099-3120. PubMed ID: 29779041
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of microglial activity as a therapy for Alzheimer's disease.
Tan B; Choi RH; Chin TJ; Kaur C; Ling EA
Front Biosci (Schol Ed); 2012 Jun; 4(4):1402-12. PubMed ID: 22652882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
